Effectiveness of rimegepant across multiple acute migraine attacks: A real-world, prospective, multicentric study
Cephalalgia · 2026-10 · 46 (10)
DOI: 10.1177/03331024261484897 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cephalalgia, online erschienen am 27.10.2026. Verfasst von Gloria Vaghi und 50 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy. Hauptthemen laut MEDLINE: Migraine Disorders, Piperidines, Pyridines. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Aim
Rimegepant is an effective acute migraine treatment, with limited evidence regarding its consistency across multiple migraine attacks. The primary aim is to assess rimegepant effectiveness across multiple migraine attacks.
Methods
In this real-world, prospective, multicentric study we assessed participants who treated up to four different migraine attacks with rimegepant 75 mg orally disintegrating tablet. Data was collected every 30 min from migraine onset up to 2 h post dose using an electronic diary. Our primary outcome was 2-h pain freedom across all-treated attacks; secondary outcomes were: consistency of response (percentage of participants who achieved 2-h pain freedom in at least two treated attacks), safety and tolerability.
Results
We enrolled 191 participants (80.1% females, age 44.8 [43.2–46.5] years, disease duration 28.4 [25.0–31.8] years, 27.7% with chronic migraine, 9.6 [8.9–10.9] baseline monthly migraine days-MMDs). We collected data from 377 migraine attacks (191 first-treated, 110 s-treated, 46 third-treated and 30 fourth-treated). Two-hour pain freedom was achieved in 44.6% (168/377) of treated attacks [39.3–49.6]. After correction for age, timing of rimegepant intake, baseline pain intensity, ongoing preventive treatment, and number of preventive drug classes that previously proved ineffective, 2-h pain freedom was associated with female sex (odds ratio (OR) = 2.3 [1.2–4.3], p = 0.012), no ongoing mAbs treatment (OR = 3.2 [1.6–6.4], p = 0.001), and lower MMDs (OR = 1.05 [1.0–1.1], p = 0.002). Consistency of response was 36.4% [27.3–45.5] (40/110). Participants reporting at least one adverse event were 11.5% (22/191).
Conclusion
Our study confirms the effectiveness of rimegepant in nearly half of treated attacks and describe the consistency of response in a relatively large real-world population where one out of five participants achieved 2-h pain freedom in all-treated migraine attacks. No new safety signals were identified.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
- Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, IRCCS Mondino Foundation, Pavia, Italy.
- Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, University of L'Aquila, L'Aquila, Italy.
- Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome Polo Pontino, Sapienza University of Rome, Latina, Italy.
- Headache Centre, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", University of Campania "Luigi Vanvitelli", Naples, Italy.
- Headache Center of Clinical Neurology of Istituto Clinico Città Di Brescia, Brescia, Italy.
ORCID-Profile: Gloria Vaghi, Raffaele Ornello, Gabriele Sebastianelli, Francesco Casillo, Antonio Russo, Marcello Silvestro, Francesca Pistoia, Gennaro Saporito, Giorgio Dalla Volta, Marco Bolchini, Andrea Burgalassi, Antonio Munafò, Danilo Antonio Montisano, Licia Grazzi, Maria Pia Prudenzano, Davide Mascarella, Gianluca Coppola, Gianluca Avino, Catello Vollono, Marina Romozzi, Mariarosaria Valente, Giovanna Carlucci, Simona Guerzoni, Stefania Battistini, Elisa Maria Piella, Innocenzo Rainero, Maria Albanese, Michele Trimboli, Alberto Doretti, Federico De Santis, Simona Sacco, Cristina Tassorelli, Luigi Francesco Iannone, Francesco De Cesaris, Sabina Cevoli, Sara Pez, Flavia Lo Castro, Chiara Serafini, Eleonora Colombo, Alessandro Cocuzza, Roberto De Icco
Förderung
- Ministero della Salute
Zitieren
APA
Vaghi, G., Ornello, R., Sebastianelli, G., Casillo, F., Russo, A., Silvestro, M., Pistoia, F., Saporito, G., Dalla Volta, G., Bolchini, M., Burgalassi, A., Munafò, A., Montisano, D. A., Grazzi, L., Prudenzano, M. P., Mascarella, D., Coppola, G., Mampreso, E., Avino, G., …, & De Icco, R. (2026). Effectiveness of rimegepant across multiple acute migraine attacks: A real-world, prospective, multicentric study. Cephalalgia, 46(10). https://doi.org/10.1177/03331024261484897
Vancouver
Vaghi G, Ornello R, Sebastianelli G, Casillo F, Russo A, Silvestro M, et al. Effectiveness of rimegepant across multiple acute migraine attacks: A real-world, prospective, multicentric study. Cephalalgia. 2026;46(10). doi:10.1177/03331024261484897
BibTeX
@article{Vaghi2026,
author = {Vaghi, Gloria and Ornello, Raffaele and Sebastianelli, Gabriele and Casillo, Francesco and Russo, Antonio and Silvestro, Marcello and Pistoia, Francesca and Saporito, Gennaro and Dalla Volta, Giorgio and Bolchini, Marco and Burgalassi, Andrea and Munafò, Antonio and Montisano, Danilo Antonio and Grazzi, Licia and Prudenzano, Maria Pia and Mascarella, Davide and Coppola, Gianluca and Mampreso, Edoardo and Avino, Gianluca and Vollono, Catello and Romozzi, Marina and Valente, Mariarosaria and Carlucci, Giovanna and Guerzoni, Simona and Battistini, Stefania and Granato, Antonio and Piella, Elisa Maria and Rainero, Innocenzo and Albanese, Maria and Trimboli, Michele and Doretti, Alberto and Santis, Federico De and Sacco, Simona and Tassorelli, Cristina and Iannone, Luigi Francesco and Cortinovis, Matteo and Chiarugi, Alberto and De Cesaris, Francesco and Gentile, Martino and Fallacara, Adriana and Cevoli, Sabina and Grassi, Enrico and Pez, Sara and Lo Castro, Flavia and Bartole, Luca and Agostinelli, Alessia and Serafini, Chiara and D'Agostino, Vittoria Carla and Colombo, Eleonora and Cocuzza, Alessandro and De Icco, Roberto},
title = {Effectiveness of rimegepant across multiple acute migraine attacks: A real-world, prospective, multicentric study},
journal = {Cephalalgia},
year = {2026},
volume = {46},
number = {10},
doi = {10.1177/03331024261484897}
}
EUVIMED